Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients

Cancer Epidemiology

Volumn 38, Issue 4, 2014, Pages 427-434

  Harries, M ^a   Taylor, A ^b   Holmberg, L ^a   Agbaje, O ^a   Garmo, H ^a   Kabilan, S ^a   Purushotham, A ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b AMGEN LTD   (United Kingdom)

Author keywords

Bone metastases; Breast cancer; Incidence; Survival

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; BONE NEOPLASMS; BREAST TUMOR; CARCINOMA; INCIDENCE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SECONDARY;

ADULT; AGED; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84904538676     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2014.05.005     Document Type: Article

References (30)

1. Stats CRUC Breast cancer statistics: key facts 2012, Available from: http://info.cancerresearchuk.org/cancerstats/types/breast/index.htm?script=true [cited 29.11.12].
2. UK CR Breast cancer survival statistics 2012, Available from: http://info.cancerresearchuk.org/cancerstats/types/breast/survival/ [cited 29.11.12].
3. Solomayer E.F., Diel I.J., Meyberg G.C., Gollan C., Bastert G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 2000, 59:271-278.
4. Lipton A., Theriault R.L., Hortobagyi G.N., Simeone J., Knight R.D., Mellars K., et al. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer 2000, 88:1082-1090.
5. Briasoulis E., Karavasilis V., Kostadima L., Ignatiadis M., Fountzilas G., Pavlidis N. Metastatic breast carcinoma confined to bone: portrait of a clinical entity. Cancer 2004, 101:1524-1528.
6. Jacobson A.F., Shapiro C.L., Van den Abbeele A.D., Kaplan W.D. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma. Cancer 2001, 91:17-24.
7. Plunkett T.A., Smith P., Rubens R.D. Risk of complications from bone metastases in breast cancer: implications for management. Eur J Cancer 2000, 36:476-482.
8. Wedin R., Bauer H.C., Rutqvist L.E. Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients. Cancer 2001, 92:257-262.
9. Kalbfleisch D., Prentice R. The statistical analysis of failure time data 2011, John Wiley, New York, NY.
10. Fine J., Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
11. Vichapat V. Metachronus contralateral breast cancer: an analysis of risk factors, prognosis and patterns of distant metastases 2012, King's College London, United Kingdom.
12. Koizumi M., Yoshimoto M., Kasumi F., Iwase T. An open cohort study of bone metastasis incidence following surgery in breast cancer patients. BMC Cancer 2010, 10:381.
13. Jensen A.O., Jacobsen J.B., Norgaard M., Yong M., Fryzek J.P., Sorensen H.T. Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 2011, 11:29.
14. Sathiakumar N., Delzell E., Morrisey M.A., Falkson C., Yong M., Chia V., et al. Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999-2006. Breast Cancer Res Treat 2012, 131:231-238.
15. Coleman R.E., Rubens R.D. The clinical course of bone metastases from breast cancer. Br J Cancer 1987, 55:61-66.
16. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative G.
17. Clarke M., Coates A.S., Darby S.C., Davies C., Gelber R.D., et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. Lancet 2008, 371:29-40. Early Breast Cancer Trialists' Collaborative G.
18. Anders C.K., Hsu D.S., Broadwater G., Acharya C.R., Foekens J.A., Zhang Y., et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol: Off J Am Soc Clin Oncol 2008, 26:3324-3330.
19. Goldhirsch A., Gelber R.D., Yothers G., Gray R.J., Green S., Bryant J., et al. Adjuvant therapy for very young women with breast cancer: need for tailored treatments. J Natl Cancer Inst Monogr 2001, 44-51.
20. Mathew A., Pandey M., Rajan B. Do younger women with non-metastatic and non-inflammatory breast carcinoma have poor prognosis?. World J Surg Oncol 2004, 2:2.
21. Kennecke H., Yerushalmi R., Woods R., Cheang M.C., Voduc D., Speers C.H., et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol: Off J Am Soc Clin Oncol 2010, 28:3271-3277.
22. Hasebe T., Imoto S., Yokose T., Ishii G., Iwasaki M., Wada N. Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study. Human Pathol 2008, 39:681-693.
23. Ahn S.G., Lee H.M., Cho S.H., Lee S.A., Hwang S.H., Jeong J., et al. Prognostic factors for patients with bone-only metastasis in breast cancer. Yonsei Med J 2013, 54:1168-1177.
24. Anan K., Mitsuyama S., Koga K., Tanabe R., Saimura M., Tanabe Y., et al. Disparities in the survival improvement of recurrent breast cancer. Breast Cancer 2010, 17:48-55.
25. Cady B., Nathan N.R., Michaelson J.S., Golshan M., Smith B.L. Matched pair analyses of stage IV breast cancer with or without resection of primary breast site. Ann Surg Oncol 2008, 15:3384-3395.
26. Yavas O., Hayran M., Ozisik Y. Factors affecting survival in breast cancer patients following bone metastasis. Tumori 2007, 93:580-586.
27. Santini D., Procopio G., Porta C., Ibrahim T., Barni S., Mazzara C., et al. Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. PloS one 2013, 8:e83026.
28. Silvestris N., Pantano F., Ibrahim T., Gamucci T., De Vita F., Di Palma T., et al. Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PloS one 2013, 8:e74402.
29. Santini D., Tampellini M., Vincenzi B., Ibrahim T., Ortega C., Virzi V., et al. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol: Off J Eur Soc Med Oncol/ESMO 2012, 23:2072-2077.
30. Sugiura H., Yamada K., Sugiura T., Hida T., Mitsudomi T. Predictors of survival in patients with bone metastasis of lung cancer. Clin Orthop Relat Res 2008, 466:729-736.